Uncaria tomentosa acts as a potent TNF-α inhibitor through NF-κB

Journal of Ethnopharmacology

Volumn 127, Issue 3, 2010, Pages 685-693

  Allen Hall, Lisa ^a,b   Arnason, John T ^d   Cano, Pablo ^b   Lafrenie, Robert M ^a,b,c  

^a LAURENTIAN UNIVERSITY   (Canada)

^b SUDBURY REGIONAL HOSPITAL   (Canada)

^c NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cytokine; Inflammation; NF B; TNF ; Uncaria tomentosa

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; SN 50; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCARIA TOMENTOSA EXTRACT; ZIDOVUDINE;

ARTICLE; CELL COUNT; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; GENE ACTIVITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UNCARIA TOMENTOSA;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTI-INFLAMMATORY AGENTS; CAT'S CLAW; CELL DEATH; CELL LINE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

MARTYNIA ANNUA; UNCARIA TOMENTOSA;

EID: 76149105129     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.12.004     Document Type: Article

References (43)

1. Ahmed-Choudhury J., Russell C.L., Randhawa S., Young L.S., Adams D.H., Afford S.C. Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation. Molecular Biology of the Cell 2003, 14:1334-1345.
2. Allen-Hall L., Cano P., Arnason J.T., Rojas R., Lock O., Lafrenie R.M. Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression of IL-1beta and TNF-alpha. Journal of Ethnopharmacology 2007, 109:312-317.
3. Amit S., Ben-Neriah Y. NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach. Seminars in Cancer Biology 2003, 13:15-28.
4. Bright J.J. Curcumin and autoimmune disease. Advances in Experimental Medicine and Biology 2007, 595:425-451.
5. Cheng A.C., Jian C.B., Huang Y.T., Lai C.S., Hsu P.C., Pan M.H. Induction of apoptosis by Uncaria tomentosa through reactive oxygen species production, cytochrome c release, and caspases activation in human leukemia cells. Food and Chemical Toxicology 2007, 45:2206-2218.
6. Garcia Prado E., Garcia Gimenez M.D., De la Puerto Vasquez R., Espartero Sanchez J.L., Saenz Rodriguez M.T. Antiproliferative effects of mitraphylline, a pentacyclic oxindole alkaloid of Uncaria tomentosa on human glioma and neuroblastoma cell lines. Phytomedicine 2007, 14:280-284.
7. Ghosh S.K., Wood C., Boise L.H., Mian A.M., Deyev V.V., Feuer G., Toomey N.L., Shank N.C., Cabral L., Barber G.N., Harrington W.J. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood 2003, 101:2321-2327.
8. Goncalves C., Dinis T., Batista M.T. Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: a mechanism for anti-inflammatory activity. Phytochemistry 2005, 66:89-98.
9. Gopalakrishnan A., Tony Kong A.N. Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells. Food and Chemical Toxicology 2008, 46:1257-1270.
10. Granet C., Maslinski W., Miossec P. Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes. Arthritis Research and Therapy 2004, 6:R190-R198.
11. Hacker H., Karin M. Is NF-kappaB2/p100 a direct activator of programmed cell death?. Cancer Cell 2002, 2:431-433.
12. Hagemann T., Wilson J., Kulbe H., Li N.F., Leinster D.A., Charles K., Klemm F., Pukrop T., Binder C., Balkwill F.R. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. Journal of Immunology 2005, 175:1197-1205.
13. Handel M.L., Nguyen L.Q., Lehmann T.P. Inhibition of transcription factors by anti-inflammatory and anti-rheumatic drugs: can variability in response be overcome?. Clinical and Experimental Pharmacology and Physiology 2000, 27:139-144.
14. Heitzman M.E., Neto C.C., Winiarz E., Vaisberg A.J., Hammond G.B. Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae). Phytochemistry 2005, 66:5-29.
15. Hou D.X., Masuzaki S., Hashimoto F., Uto T., Tanigawa S., Fujii M., Sakata Y. Green tea proanthocyanidins inhibit cyclooxygenase-2 expression in LPS-activated mouse macrophages: molecular mechanisms and structure-activity relationship. Archives of Biochemistry and Biophysics 2007, 460:67-74.
16. Lee S.Y., Lee M.S., Cherla R.P., Tesh V.L. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cellular Microbiology 2008, 10:770-780.
17. Lee K.Y., Ito K., Hayashi R., Jazrawi E.P., Barnes P.J., Adcock I.M. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. Journal of Immunology 2006, 176:603-615.
18. Lee S.J., Park S.S., Cho Y.H., Park K., Kim E.J., Jung K.H., Kim S.K., Kim W.J., Moon S.K. Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways. Oncology Reports 2008, 19:1007-1013.
19. Lich J.D., Williams K.L., Moore C.B., Arthur J.C., Davis B.K., Taxman D.J., Ting J.P. Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. Journal of Immunology 2007, 178:1256-1260.
20. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. Journal of Biological Chemistry 1995, 270:14255-14258.
21. Lu X., Liu H., Wang L., Schaefer S. Activation of NF-kappaB is a critical element in the anti-apoptotic effect of anesthetic preconditioning. American Journal of Physiology. Heart and Circulatory Physiology 2009, 296:H1296-H1304.
22. Mittal A., Papa S., Franzoso G., Sen R. NF-kappaB-dependent regulation of the timing of activation-induced cell death of T lymphocytes. Journal of Immunology 2006, 176:2183-2189.
23. Nadiminty N., Chun J.Y., Lou W., Lin X., Gao A.C. NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation. Prostate 2008, 68:1725-1733.
24. Nakamura T., Datta R., Kharbanda S., Kufe D. Regulation of jun and fos gene expression in human monocytes by the macrophage colony-stimulating factor. Cell Growth and Differentiation 1991, 2:267-272.
25. Orange J.S., May M.J. Cell penetrating peptide inhibitors of nuclear factor-kappaB. Cellular and Molecular Life Sciences 2008, 65:3564-3591.
26. Ortiz-Lazareno P.C., Hernandez-Flores G., Dominguez-Rodriguez J.R., Lerma-Diaz J.M., Jave-Suarez L.F., Aguilar-Lemarroy A., Gomez-Contreras P.C., Scott-Algara D., Bravo-Cuellar A. MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-kappaB and activator protein-1. Immunology 2008, 124:534-541.
27. Paur I., Austenaa L.M., Blomhoff R. Extracts of dietary plants are efficient modulators of nuclear factor kappa B. Food and Chemical Toxicology 2008, 46:1288-1297.
28. Pickering B.M., de Mel S., Lee M., Howell M., Habens F., Dallman C.L., Neville L.A., Potter K.N., Mann J., Mann D.A., Johnson P.W., Stevenson F.K., Packham G. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells. Oncogene 2007, 26:1166-1177.
29. Pilarski R., Poczekaj-Kostrzewska M., Ciesiolka D., Szyfter K., Gulewicz K. Antiproliferative activity of various Uncaria tomentosa preparations on HL-60 promyelocytic leukemia cells. Pharmacological Reports 2007, 59:565-572.
30. Piscoya J., Rodriguez Z., Bustamante S.A., Okuhama N.N., Miller M.J., Sandoval M. Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis. Inflammation Research 2001, 50:442-448.
31. Reis S.R., Valente L.M., Sampaio A.L., Siani A.C., Gandini M., Azeredo E.L., D'Avila L.A., Mazzei J.L., Henriques M.G., Kubelka C.F. Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue Virus-2. International Immunopharmacology 2008, 8:468-476.
32. Sandoval M., Charbonnet R.M., Okuhama N.N., Roberts J., Krenova Z., Trentacosti A.M., Miller M.J. Cat's claw inhibits TNFalpha production and scavenges free radicals: role in cytoprotection. Free Radical Biology and Medicine 2000, 29:71-78.
33. Sandoval M., Okuhama N.N., Zhang X.J., Condezo L.A., Lao J., Angeles' F.M., Musah R.A., Bobrowski P., Miller M.J. Anti-inflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine 2002, 9:325-337.
34. Schumm K., Rocha S., Caamano J., Perkins N.D. Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit. EMBO Journal 2006, 25:4820-4832.
35. Setty A.R., Sigal L.H. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Seminars in Arthritis and Rheumatism 2005, 34:773-784.
36. Shiozawa S., Tsumiyama K. Pathogenesis of rheumatoid arthritis and c-Fos/AP-1. Cell Cycle 2009, 15:10.
37. Solt L.A., Madge L.A., Orange J.S., May M.J. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta. Journal of Biological Chemistry 2007, 282:8723-8733.
38. Torgerson T.R., Colosia A.D., Donahue J.P., Lin Y.Z., Hawiger J. Regulation of NF-kappaB, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappaB. Journal of Immunology 1998, 161:6084-6092.
39. Walmsley S.R, Print C., Farahi N., Peyssonnaux C., Johnson R.S., Cramer T., Sobolewski A., Condliffe A.M., Cowburn A.S., Johnson N., Chilvers E.R. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. Journal of Experimental Medicine 2005, 201:105-115.
40. Wang Z., Zhang B., Yang L., Ding J., Ding H.F. Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression. Journal of Biological Chemistry 2008, 283:10698-10706.
41. Zhang G., Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. Journal of Endotoxin Research 2000, 6:453-457.
42. Zhang X., Huang X., Olumi A.F. Repression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate cancer cells. International Journal of Cancer 2009, 124:1980-1989.
43. Zhang J., Warren M.A., Shoemaker S.F., Ip M.M. NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB. Endocrinology 2007, 148:268-278.